Meet Our World‑Class Facilities
JYMed Peptide operates two state‑of‑the‑art manufacturing sites in China, each designed to meet global cGMP standards while delivering integrated peptide API and sterile formulation capabilities.
Hubei API manufacturing site
Peptide API Manufacturing Excellence
Situated in the Xian’an Economic Development Zone, our Hubei facility is the cornerstone of JYMed Peptide’s large‑scale peptide API production. Spanning a 300‑acre campus with more than 54,000 m² of cutting‑edge infrastructure, this site was built from the ground up to support complex peptide synthesis and high‑volume production for both commercial and clinical markets. The facility integrates Solid Phase Peptide Synthesis (SPPS) and Liquid Phase Peptide Synthesis (LPPS) technologies, supported by automated preparative chromatography systems, continuous purification processes, and extensive capacity for future expansion. With strict adherence to international cGMP standards, the Hubei site has successfully passed multiple US FDA and NMPA audits, earning its reputation as a reliable partner for pharmaceutical and biotech companies worldwide.
Hubei JXBio
Diving into the Numbers
54,000 m²: size of the Hubei API campus, housing 30 000 L + of SPPS/LPPS reactor volume.
10 cGMP lines: supporting large (5–50 kg), small/medium (100 g–5 kg) and cosmetic (1–100 kg) batch scales.
SPPS/LPPS reactor capacity
4+ tons: current annual peptide output, expanding to 10+ tons by 2026.
Smart Design, Scalable Solutions
Infrastructure Highlights:
Quality Management System (cGMP, ISO, ICH)
We operate a comprehensive QMS aligned with cGMP, ISO9001, and ICH guidelines. Through robust procedures in deviation handling, change control, quality review, and self-inspection, we ensure end-to-end product quality and data integrity for high-standard peptide APIs.
Large-Scale & Intelligent Production Facility
With over 190,000 m² of modern facilities including multiple Class A cleanrooms, we deliver flexible peptide manufacturing from grams to 50 kg. Equipped with advanced synthesis, purification, isolation, and lyophilization systems, we provide reliable CMO/CDMO solutions.
Data Integrity & Global Compliance
Our fully validated computerized systems feature audit trails, access controls, and automated backups. Integrated cold-chain and environmental monitoring ensure full traceability and compliance with NMPA, FDA, and EMA requirements.
Green Production & Safety Assurance System
We maintain environmentally responsible operations with a 700-ton/day wastewater treatment system and exhaust gas controls. Supported by strict EHS protocols, occupational health programs, and emergency preparedness, we ensure safe and sustainable supply chain delivery.
Shenzhen FDF manufacturing site
Sterile Formulation & CDMO Services
Located in Shenzhen’s thriving biotech hub, Shenzhen JXBio is our center of excellence for peptide formulation and fill‑finish services. Established in 2013 as a wholly owned subsidiary of JYMed Peptide, the facility houses multiple GMP‑compliant production lines for cartridges, small‑volume injections, and lyophilized powders. It provides an integrated platform for contract development and manufacturing (CDMO) services, supporting clients from clinical development through to commercial supply. Our highly trained technical teams implement rigorous process controls, sterile handling protocols, and state‑of‑the‑art filling and freeze‑drying equipment to ensure every batch meets the highest international standards. Having successfully passed repeated NMPA cGMP audits and multiple PAI inspections, Shenzhen JXBio has become a trusted partner for pharmaceutical companies looking to bring innovative peptide therapies to market.
Smart Design, Scalable Solutions
Infrastructure Highlights:
Multi-Dosage Formulation CDMO Platform
We offer GMP-certified production for lyophilized, vial, and cartridge injectables, delivering end-to-end CDMO services from clinical to commercial scale. Our flexible lines support fast turnaround across development stages.
Global Quality & Regulatory Compliance
Our quality system meets cGMP, ICH, FDA, EMA, and NMPA requirements. With full data integrity, validation, and audit trail support, we ensure compliance for submissions in key global markets.
Shenzhen JXBio
Diving into the Numbers
Four GMP‑compliant formulation lines for cartridge, small‑volume, and lyophilized powder injections
Syringe line filling speed: 200 vials/minute (30M vials/year)
Cartridge line filling speed: 70 bottles/minute (10M bottles/year)
Freeze‑dryer line capacity: 22,000 vials per batch (5M vials/year)